Drug Delivery

Aug 28, 2017
By BioPharm International Editors
Genentech gets priority review for its application seeking a new indication for its anti-cancer drug, Gazyva (obinutuzumab), in treating follicular lymphoma.
Aug 16, 2017
By BioPharm International Editors
The US Patent and Trademark Office issued three new patents that extend protection for Alexion’s rare-disease drug, Soliris, for an additional 10 years.
Aug 07, 2017
By BioPharm International Editors
Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.
Jul 25, 2017
By BioPharm International Editors
Recipharm set up a manufacturing line at its facility in Sweden using LIDD’s NanoZolid technology.
Jul 21, 2017
By BioPharm International Editors
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
Jun 28, 2017
By BioPharm International Editors
An NIH study examined a dissolving microneedle technology as a way to deliver the influenza vaccine to patients.
Jun 07, 2017
By BioPharm International Editors
The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.
May 31, 2017
By BioPharm International Editors
Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.
Apr 27, 2017
By BioPharm International Editors
A new NIH study in rats shows that the antidepressant amitriptyline combined with drugs to treat central nervous system diseases may enhance drug delivery to the brain.
Apr 01, 2017
BioPharm International
Including next-gen antibodies in pharma pipelines is considered essential for future success.
native1_300x100
lorem ipsum